anonymous
Guest
anonymous
Guest
Eye care division will be complete dissolved by end of Q2. Sad.
This made me spit out my drinkFalse.
Just long overdue clean up.
Check back in Q2 2026 and look at results.
Not defending the previous weak leadership, there is no way “Viatris” leadership rights this ship. At there core, they’re a company comprised of industry leftovers.False.
Just long overdue clean up.
Check back in Q2 2026 and look at results.
What's the problem? Seems the Tyrvaya should be able to carve out something. Is is distribution? Payer access?Eye care products are extremely weak at best. I think the whole division did 40m in sales last year. Other Viatris divisions do that in a month.
Whole system is crumbling!! I don't think board cares anymore about dead rotten pig, I see no captain leader that could resuscitateNot defending the previous weak leadership, there is no way “Viatris” leadership rights this ship. At there core, they’re a company comprised of industry leftovers.
Just had another Mass exist. Replaced poor leadership with poorer leadership. It’s a sinking ship.Whole system is crumbling!! I don't think board cares anymore about dead rotten pig, I see no captain leader that could resuscitate
Hope you were one of them with that poor command of English. I think you meant, mass (uncapitalized) and exodus?Just had another Mass exist. Replaced poor leadership with poorer leadership. It’s a sinking ship.
Shit company, shit people shit strategy shit prouduct. At least the original leadership is gone.Hope you were one of them with that poor command of English. I think you meant, mass (uncapitalized) and exodus?
We are in bad shape. I've been here 3+ years and watched a culture of activity get rewarded over a culture of performance.
We've had 2 launches and how did we do?
Ryzumvi? Absolute failure. Doesn't even sell a million.
Tyrvaya? An easily differentiated option, sub-$100 million and since Q4 of last year our sales are plummeting. Sure, we can blame Medicare, but we have the last place share in the market for other reasons.
What do you think the board was going to do? Just keep paying us to have 2 of the worst launch performances in industry history?
Leadership had to be replaced. I don't know much about any of the new guys, but I hope they can get some things turned and make this place better. I doubt they can do it without replacing 99% of the RSMs and 90% of us. Too much entitlement and complacency in the ECD.
Well then, tomorrow it's back to whining and complaining about change, but the bottom line is we suck.
Sounds like the new leadership is on the thread. I’m not defending the old leadership but there is no path to eyecare success. The lack of communication is deliberate, stay silent and have the rest of your top paying reps and managers leave and backfill them with much cheaper talentI still believe. I think our product is fine. We just launched wrong. Hoping the new leadership right things. Like what I've seen so far, but I've been fooled before. Time will tell.
You sound like a pussy. What has any DM, RSM or VP ever said anywhere that caused your performance to be better. For me, never. Get out and make calls and grow. That simple.Sounds like the new leadership is on the thread. I’m not defending the old leadership but there is no path to eyecare success. The lack of communication is deliberate, stay silent and have the rest of your top paying reps and managers leave and backfill them with much cheaper talent
And if you believe new leadership is bringing our division back to growth, you’re smoking meth. The ship has sailed.Yeah, former leaders communicated all the time and lead us to a 2 share. Not sure what there is to say.
Only thing bring this back is us. We need to start making more good calls, in place of activity calls. We need to start being competitive. We need to start selling.And if you believe new leadership is bringing our division back to growth, you’re smoking meth. The ship has sailed.
I appreciate the Kool Aide you’re drinking. Our access is worse, the field has gotten crowded w Alcon’s drug, doctors love Alcon verses the latter w Viatris, there is no new meaningful data coming out on either drug, you’ve cut every budget in commercial, the turnover is high and not stopping. Scott put his lackey in charge….spend 5 minutes talking to him and you’ll have zero confidence in this ship being course corrected. Those aren’t excuses rather than indicators of limited success.Only thing bring this back is us. We need to start making more good calls, in place of activity calls. We need to start being competitive. We need to start selling.
If you are the type who is using the excuse that you are waiting for "Leadership" to inspire you and give you a message then you are the problem and 99% of the reason we have a 1.5% share. Feels good to blame it on others and wait around to be told what to do.